- Home
- EGY vs MLAB Comparison
EGY vs MLAB Comparison
Compare EGY & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EGY | MLAB |
|---|---|---|
| Founded | 1985 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Industrial Machinery/Components |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 412.9M | 489.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EGY | MLAB |
|---|---|---|
| Price | $4.80 | $86.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $7.30 | ★ $83.00 |
| AVG Volume (30 Days) | ★ 1.1M | 104.3K |
| Earning Date | 03-12-2026 | 02-03-2026 |
| Dividend Yield | ★ 5.20% | 0.74% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $389,951,000.00 | $245,255,000.00 |
| Revenue This Year | N/A | $4.96 |
| Revenue Next Year | $21.53 | $5.27 |
| P/E Ratio | $17.82 | ★ N/A |
| Revenue Growth | N/A | ★ 7.39 |
| 52 Week Low | $3.00 | $55.45 |
| 52 Week High | $4.84 | $155.12 |
Technical Indicators
Market Signals| Indicator | EGY | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 85.48 | 56.16 |
| Support Level | $3.47 | $82.32 |
| Resistance Level | $3.78 | $89.43 |
| Average True Range (ATR) | 0.19 | 4.35 |
| MACD | 0.13 | 0.02 |
| Stochastic Oscillator | 96.82 | 67.51 |
Price Performance
Historical ComparisonAbout EGY VAALCO Energy Inc.
VAALCO Energy Inc is an independent energy company operating in the United States. It is principally engaged in the acquisition, exploration, development, and production of crude oil and natural gas. The company operates through geographical segments namely Gabon, Egypt, Canada, Equatorial Guinea, and Cote d'Ivoire. The company generates maximum revenue from the Gabon segment.
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.